Marijuana Reclassification Reports Push Cannabis Stocks and Crypto Higher
Reports that the Trump administration is moving to reclassify marijuana from Schedule I to a lower federal drug classification sent cannabis-related equities, ETFs, and at least one cannabis-themed
Massachusetts Cannabis Regulators Expand Retail License Caps and Rewrite Equity Rules
The Massachusetts Cannabis Control Commission voted on June 17th to approve Emergency Regulations that raise the retail license cap, increase sales and possession limits, and revise the ownership
Hemp CBD Sellers Keep Losing Bank Accounts the Law Says They Should Have
A hemp retailer can hold a current certificate of analysis on every SKU, pass every compliance audit, and still receive a processor termination notice with no warning and no real explanation. The
DOJ Rescheduling Gives Medical Cannabis Operators a Tax Opening - With Limits
The U.S. Department of Justice's move to downgrade cannabis from Schedule I to Schedule III under the Controlled Substances Act represents the most significant federal policy shift for the cannabis
Michigan Regulator Files Complaint Against Processor Holding Thousands of Untagged Products
Michigan's Cannabis Regulatory Agency has filed a formal complaint against VJAS 1, a licensed cannabis processor operating in Harrison Township, after an inspection uncovered more than 12,000
Federal Cannabis Rescheduling Moves the Needle Without Rewriting the Rules
The U.S. Department of Justice's April 23 announcement placing certain FDA-approved marijuana products and state-licensed medical cannabis into Schedule III of the Controlled Substances Act is real.
Helsinki Rail Disruption Forces Business Travellers to Rethink Summer Itineraries
Starting 1 June 2026, Helsinki's commuter-rail network will operate under significant constraints through early September - and for anyone scheduling meetings in Espoo's tech districts or transiting
Jushi Applies for DEA Registration as Federal Medical Cannabis Framework Takes Shape
Jushi Holdings Inc. has filed applications with the U.S. Drug Enforcement Administration seeking federal registration for certain of its state-licensed medical marijuana operations - one of the first
Gary Payton Strain Earns Its Spot on Premium Dispensary Menus Through Genetics, Not Just a Name
Celebrity-branded cannabis cultivars are, by and large, a licensing exercise dressed up as a product launch. The Gary Payton strain is the exception worth understanding - not because of the name on
Six States Move to Restrict Hemp-Derived THC Products, Reshaping Retail Compliance
A wave of state-level legislative and regulatory action is bearing down on the hemp-derived cannabinoid market. From Delaware to Virginia, lawmakers and regulators are advancing measures that would